Company intelligence / Profile preview
SynCore Biotechnology
Yilan City, Taiwansyncorebio.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
SynCore’s lead program, SB05PC (EndoTAG®‑1), has completed global Phase III interim analyses in metastatic pancreatic cancer. Previous trials did not meet primary endpoints but new protocols are targeting FOLFIRINOX-resistant patients with promising survival extension data. The pipeline includes additional oncology assets in earlier stages as well as products for ophthalmology and dermatology.
- Therapeutic areas
- OphthalmologyOncologyInfectious Diseases
- Modalities
- Small molecules (notably liposomal formulations)Conventional drugs (e.g., paclitaxel liposomal/EndoTAG®‑1)New chemical entities (NCEs)Ointments for dermatology indications
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Medigene AGMacuCLEAR Inc.Sinphar Pharmaceutical Co., Ltd.National Health Research Institutes TaiwanY-YBar AG SwitzerlandEpipole UK
Beyond the preview
Go deeper on SynCore Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SynCore Biotechnology.